Senior Scientist I, Healthcare, Quality, & Safety (HQS)

Who is USP?

The U.S. Pharmacopeial Convention (USP) is an independent scientific organization that collaborates with the
world’s leading health and science experts to develop rigorous quality standards for medicines, dietary
supplements, and food ingredients. At USP, we believe that scientific excellence is driven by a commitment to
fairness, integrity, and global collaboration. This belief is embedded in our core value of Passion for Quality and
is demonstrated through the contributions of more than 1,300 professionals across twenty global locations,
working to strengthen the supply of safe, high-quality medicines worldwide.

At USP, we value inclusive scientific collaboration and recognize that attracting diverse expertise strengthens our
ability to develop trusted public health standards. We foster an organizational culture that supports equitable
access to mentorship, professional development, and leadership opportunities. Our partnerships, standards, and
research reflect our belief that ensuring broad participation in scientific leadership results in stronger, more
impactful outcomes for global health.

USP is proud to be an equal employment opportunity employer (EEOE) and is committed to ensuring fair, merit-based selection processes that enable the best scientific minds—regardless of background—to contribute to
advancing public health solutions worldwide. We provide reasonable accommodations to individuals with
disabilities and uphold policies that create an inclusive and collaborative work environment.

Brief Job Overview

This is a professional individual contributor position that will be part of the Healthcare, Quality & Safety (HQS)
Center of Excellence under the Personalized Medicines group. This role will be responsible for leading the
development of future standards and solutions for Pharmacogenomics and Software as a Medical Device that
address the needs of healthcare professionals. This includes partnership and collaboration with USP Expert
Committees, external experts and cross-functional teams on exploring key topics such as pharmacogenomics,
digital medicine, SaMD and other emerging areas. The incumbent will lead critical evaluation of relevant
literature, scientific data and evidence and development of priority standards and solutions. This position will
collaborate with documentary scientists in the Healthcare Quality and Safety group, incorporating global
perspectives and helping to shape the engagement strategy pharmacogenomics and SaMD stakeholders and USP
solutions.

In addition, this position coordinates and facilitates the workplans related to the above with all relevant USP’s
Expert Committees and healthcare practitioner input into USP standards-setting activities. This individual will
drive outreach to key stakeholders at key conferences and related events and coordinate development of key
stakeholder forums, workshops, roundtables and education to foster engagement and promote adoption of these
standards.

How will YOU create impact here at USP?

As part of our mission to advance scientific rigor and public health standards, you will play a vital role in
increasing global access to high-quality medicines through public standards and related programs. USP prioritizes
scientific integrity, regulatory excellence, and evidence-based decision-making to ensure health systems
worldwide can rely on strong, tested, and globally relevant quality standards.

Additionally, USP’s People and Culture division, in partnership with the Equity Office, invests in leadership and
workforce development to equip all employees with the skills to create high-performing, inclusive teams. This
includes training in equitable management practices and tools to promote engaged, collaborative, and results driven work environments.

The Senior Scientist I has the following responsibilities:
• Works with the Director, Personalized Medicine to lead the development of research summaries, draft
standards, concept papers, stimuli articles, and other position papers on personalized medicines. Support the
establishment of USP’ Personalized Medicine Expert Committee and its subcommittees as important
convening bodies for the development of compendial standards that drive the adoption of pharmacogenomics,
digital therapeutics (e.g., SaMD) and personalized medicine in general.
• Utilizing the USP case-based approach, lead the planning and organizing of the personalized medicines’
standard setting activities of the four HQS expert committees (Personalized Medicine, Healthcare Information
& Technology, Healthcare Safety, Quality, and Nomenclature and Compounding). Develop a comprehensive
workplan for the